ストックスクリーナーアプリを入手
74.55
0.07%
0.055
前日終値:
$74.49
開ける：
$74.55
24時間の取引高:
728.46K
Relative Volume:
0.22
時価総額：
$16.63B
収益：
$4.04B
当期純損益:
$557.10M
株価収益率:
30.93
EPS:
2.4102
ネットキャッシュフロー:
$916.70M
1週間 パフォーマンス:
+0.06%
1か月 パフォーマンス:
-0.37%
6か月 パフォーマンス:
+14.16%
1年 パフォーマンス:
+3.91%
1日の値動き範囲:
$74.49
$74.60
1週間の範囲:
$74.46
$74.60
52週間の値動き範囲:
$51.90
$75.34
Hologic Inc Stock (HOLX) Company Profile
HOLX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
74.55 | 16.62B | 4.04B | 557.10M | 916.70M | 2.4102 |
|
ISRG
Intuitive Surgical Inc
|
557.10 | 200.77B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
194.17 | 55.29B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
76.91 | 38.71B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
243.63 | 35.16B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
40.47 | 33.06B | 27.43B | 1.27B | 1.01B | 1.5829 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-21 | ダウングレード | BNP Paribas Exane | Outperform → Neutral |
| 2025-10-07 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-08-18 | アップグレード | Argus | Hold → Buy |
| 2025-08-06 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-07-09 | アップグレード | Citigroup | Neutral → Buy |
| 2025-05-27 | 繰り返されました | Needham | Hold |
| 2025-03-03 | ダウングレード | Argus | Buy → Hold |
| 2025-02-06 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | ダウングレード | Needham | Buy → Hold |
| 2024-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2024-12-10 | 開始されました | Jefferies | Hold |
| 2024-12-10 | 繰り返されました | Needham | Buy |
| 2024-10-01 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-06-27 | 開始されました | Stephens | Overweight |
| 2024-04-03 | アップグレード | Citigroup | Neutral → Buy |
| 2023-07-14 | アップグレード | Needham | Hold → Buy |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | 開始されました | Mizuho | Buy |
| 2022-07-20 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-07-20 | 開始されました | UBS | Neutral |
| 2022-07-18 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-04-25 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2021-12-15 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-10-14 | 開始されました | Redburn | Neutral |
| 2021-07-06 | アップグレード | Evercore ISI | In-line → Outperform |
| 2020-11-20 | ダウングレード | Needham | Buy → Hold |
| 2020-11-05 | 繰り返されました | Needham | Buy |
| 2020-06-30 | アップグレード | Cowen | Market Perform → Outperform |
| 2020-06-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | 繰り返されました | Needham | Buy |
| 2020-04-30 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | 繰り返されました | Needham | Buy |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2020-01-02 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-09-26 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | 繰り返されました | Needham | Buy |
| 2019-05-02 | 繰り返されました | Needham | Buy |
| 2019-01-31 | 繰り返されました | Needham | Buy |
| 2019-01-02 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | 開始されました | UBS | Neutral |
| 2018-09-13 | ダウングレード | BofA/Merrill | Buy → Neutral |
すべてを表示
Hologic Inc (HOLX) 最新ニュース
Key facts: Blackstone's stock down 10.2% in 2025; partners with TPG on Hologic - TradingView — Track All Markets
Agree To Buy Hologic At $70, Earn 1.4% Annualized Using Options - Nasdaq
The Future of Bone Sonometer Market 2032 Industry Forecast - openPR.com
Skin Rejuvenation Devices Market Forecast Report: Strategic - openPR.com
Hologic's GYN Surgical Segment Looks Poised for Long-Term Growth - Yahoo Finance
Spotting Winners: Hologic (NASDAQ:HOLX) And Medical Devices & SuppliesImaging, Diagnostics Stocks In Q3 - Yahoo Finance
Hologic stock (HOLX) after-hours on Dec. 24, 2025: CVR milestone risk, Blackstone–TPG deal spread, and what to watch before the next market open - ts2.tech
Hologic says 2026 CVR is more challenging with stopped shipment of product (HOLX:NASDAQ) - Seeking Alpha
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock - sharewise.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Diamond Hill Investment Group, Inc. (Nasdaq – DHIL), Synchronoss Technologies (Nasdaq – SNCR), Forge Global Holdings, Inc. (NYSE – FRGE), Hologic, Inc. (Nasdaq – HOLX) - GlobeNewswire Inc.
HOLX vs. LH: Which MedTech Stock Is the Stronger Investment Now? - Yahoo Finance
Is Hologic Inc. stock affected by interest rate hikesWeekly Trade Summary & Long-Term Safe Investment Ideas - Улправда
Hologic, Inc. (HOLX) is attracting investor attention: Here is what you should know - MSN
Why retail investors favor Hologic Inc. stockJuly 2025 Levels & Real-Time Market Sentiment Alerts - Улправда
How sustainable is Hologic Inc. stock dividend payoutEarnings Trend Report & Weekly High Potential Alerts - Улправда
Will Hologic Inc. (HO1) stock sustain uptrend momentumQuarterly Growth Report & Verified Short-Term Plans - Улправда
Is Hologic Inc. stock positioned for digital transformation2025 Fundamental Recap & Low Drawdown Momentum Ideas - Улправда
Can Hologic Inc. stock maintain operating margins2025 Market WrapUp & AI Optimized Trading Strategy Guides - Улправда
Meeting tomorrow's diagnostic demands in today's lab - SelectScience
Why Hologic Inc. stock is recommended by analystsJuly 2025 Closing Moves & Consistent Return Investment Signals - DonanımHaber
Why Hologic Inc. stock is seen as undervaluedMarket Trend Review & Consistent Profit Alerts - DonanımHaber
Will Hologic Inc. stock reach Wall Street targetsEarnings Risk Report & Weekly High Conviction Trade Ideas - DonanımHaber
Can Hologic Inc. stock deliver surprise earnings beat2025 Volume Leaders & Real-Time Volume Surge Alerts - Улправда
Digital Breast Tomosynthesis Equipment Market Set to Boom | - openPR.com
Is Hologic Inc. stock gaining market shareJuly 2025 Big Picture & AI Powered Market Trend Analysis - ulpravda.ru
Market Outlook: Will Hologic Inc. (HO1) stock sustain uptrend momentumMarket Growth Summary & Free Accurate Trade Setup Notifications - moha.gov.vn
Hologic data highlights AI’s role in improving mammography accuracy - DOTmed
Portfolio Shifts: Can Hologic Inc. stock maintain operating marginsTrade Entry Report & Fast Exit and Entry Trade Guides - Улправда
Hologic (HOLX) shareholders have earned a 4.8% return over the last year - Yahoo Finance
Responsive Playbooks and the HOLX Inflection - news.stocktradersdaily.com
Hologic's Genius AI Detection Shows Value by Spotting Missed Cancers - sharewise.com
Hologic (HOLX) insider reports 90 shares withheld for tax obligations - Stock Titan
HOLX's Genius AI Mammography Flags Missed Breast Cancer Cases - Yahoo Finance
Why Hologic (HOLX) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Bacterial Drug Sensitivity Testing Market Future Outlook - openPR.com
Uterine Fibroid Treatment Market Forecast to 2032 Reveals Key - openPR.com
Virtual Biopsy Market Emerging Player Outperforming | GE Healthcare, Hologic, Hitachi - openPR.com
Hologic’s AI mammography tech flags previously missed breast cancers - Investing.com India
Study: AI-Powered Mammography Technology Helps Flag Breast Cancer Cases Initially Interpreted as Negative - Imaging Technology News
Hologic’s AI mammography tech flags previously missed breast cancers By Investing.com - Investing.com Nigeria
Hologic Says AI Mammography Flagged 32% of Missed Cancers in General Study - marketscreener.com
Hologic's AI-Powered Mammography Technology Flagged a Third of B - GuruFocus
Hologic’s AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening ExamsHologic, Inc. - Hologic, Inc. - Investor Relations
Hologic stock hits 52-week high at $75.14 By Investing.com - Investing.com Canada
Hologic stock hits 52-week high at $75.14 - Investing.com
Hologic's BCI test shows growing impact in endocrine therapy decisions - MSN
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
What Is Driving Hologic's Strength in the US Diagnostics Market? - The Globe and Mail
Hologic ticks higher amid report on financing for potential takeover - MSN
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Hologic Inc (HOLX) 財務データ
収益
当期純利益
現金流量
EPS
Hologic Inc (HOLX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Stamoulis Christiana | Director |
Oct 20 '25 |
Sale |
73.07 |
7,402 |
540,864 |
47,336 |
1.26%
0.77%
大文字化:
|
ボリューム (24 時間):